Company Page
Prevision Medicine
Founders
Prevision Medicine is a Swiss precision oncology company and ETH Zurich spin-off that uses its patented PrevisionOne single-cell platform to test a patient's living, tumor-derived cancer cells against an extensive library of over 100 treatment options. The platform delivers rapid, actionable clinical reports to guide oncologists in personalized treatment decisions, outperforming cohort-based strategies. Founded by a team of scientists with deep ETH roots, the company serves clinics across Switzerland and Europe with expanding interest from the Middle East and the USA.
Company Founded in 2024
